Correlation Between Spyre Therapeutics and Chemours
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Chemours at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Chemours into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and Chemours Co, you can compare the effects of market volatilities on Spyre Therapeutics and Chemours and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Chemours. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Chemours.
Diversification Opportunities for Spyre Therapeutics and Chemours
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Spyre and Chemours is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Chemours Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chemours and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Chemours. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chemours has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Chemours go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and Chemours
Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Chemours. But the stock apears to be less risky and, when comparing its historical volatility, Spyre Therapeutics is 1.01 times less risky than Chemours. The stock trades about -0.13 of its potential returns per unit of risk. The Chemours Co is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 1,793 in Chemours Co on September 1, 2024 and sell it today you would earn a total of 381.00 from holding Chemours Co or generate 21.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spyre Therapeutics vs. Chemours Co
Performance |
| Timeline |
| Spyre Therapeutics |
| Chemours |
Spyre Therapeutics and Chemours Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spyre Therapeutics and Chemours
The main advantage of trading using opposite Spyre Therapeutics and Chemours positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Chemours can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will offset losses from the drop in Chemours' long position.| Spyre Therapeutics vs. Cue Biopharma | Spyre Therapeutics vs. Tff Pharmaceuticals | Spyre Therapeutics vs. Eliem Therapeutics | Spyre Therapeutics vs. Inhibrx |
| Chemours vs. International Flavors Fragrances | Chemours vs. Air Products and | Chemours vs. PPG Industries | Chemours vs. Linde plc Ordinary |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |